-
1
-
-
84255199166
-
Molecular genetics of prostate cancer: Emerging appreciation of genetic complexity
-
Barbieri CE, Demichelis F, Rubin MA. Molecular genetics of prostate cancer: emerging appreciation of genetic complexity. Histopathology 2012;60:187-98.
-
(2012)
Histopathology
, vol.60
, pp. 187-98
-
-
Barbieri, C.E.1
Demichelis, F.2
Rubin, M.A.3
-
2
-
-
84876064523
-
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity
-
Beltran H, Yelensky R, Frampton GM, Park K, Downing SR, Macdonald TY, et al. Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity. Eur Urol 2013;63:920-6.
-
(2013)
Eur Urol
, vol.63
, pp. 920-6
-
-
Beltran, H.1
Yelensky, R.2
Frampton, G.M.3
Park, K.4
Downing, S.R.5
Macdonald, T.Y.6
-
3
-
-
0242692456
-
Molecular pathways to prostate cancer
-
Gonzalgo ML, Isaacs WB. Molecular pathways to prostate cancer. J Urol 2003;170:2444-52.
-
(2003)
J Urol
, vol.170
, pp. 2444-52
-
-
Gonzalgo, M.L.1
Isaacs, W.B.2
-
4
-
-
77249119762
-
The landscape of somatic copy-number alteration across human cancers
-
Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al. The landscape of somatic copy-number alteration across human cancers. Nature 2010;463:899-905.
-
(2010)
Nature
, vol.463
, pp. 899-905
-
-
Beroukhim, R.1
Mermel, C.H.2
Porter, D.3
Wei, G.4
Raychaudhuri, S.5
Donovan, J.6
-
5
-
-
77954255681
-
Integrative genomic profiling of human prostate cancer
-
Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010;18:11-22.
-
(2010)
Cancer Cell
, vol.18
, pp. 11-22
-
-
Taylor, B.S.1
Schultz, N.2
Hieronymus, H.3
Gopalan, A.4
Xiao, Y.5
Carver, B.S.6
-
6
-
-
48349124823
-
Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients
-
Holcomb IN, Grove DI, Kinnunen M, Friedman CL, Gallaher IS, Morgan TM, et al. Genomic alterations indicate tumor origin and varied metastatic potential of disseminated cells from prostate cancer patients. Cancer Res 2008;68:5599-608.
-
(2008)
Cancer Res
, vol.68
, pp. 5599-608
-
-
Holcomb, I.N.1
Grove, D.I.2
Kinnunen, M.3
Friedman, C.L.4
Gallaher, I.S.5
Morgan, T.M.6
-
7
-
-
63749083366
-
Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer
-
Weckermann D, Polzer B, Ragg T, Blana A, Schlimok G, Arnholdt H, et al. Perioperative activation of disseminated tumor cells in bone marrow of patients with prostate cancer. J Clin Oncol 2009;27: 1549-56.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1549-56
-
-
Weckermann, D.1
Polzer, B.2
Ragg, T.3
Blana, A.4
Schlimok, G.5
Arnholdt, H.6
-
8
-
-
27344451557
-
Recurrent fusion of tmprss2 and ets transcription factor genes in prostate cancer
-
Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005;310:644-8.
-
(2005)
Science
, vol.310
, pp. 644-8
-
-
Tomlins, S.A.1
Rhodes, D.R.2
Perner, S.3
Dhanasekaran, S.M.4
Mehra, R.5
Sun, X.W.6
-
9
-
-
34547642493
-
Distinct classes of chromosomal rearrangements create oncogenic ets gene fusions in prostate cancer
-
Tomlins SA, Laxman B, Dhanasekaran SM, Helgeson BE, Cao X, Morris DS, et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 2007; 448:595-9.
-
(2007)
Nature
, vol.448
, pp. 595-9
-
-
Tomlins, S.A.1
Laxman, B.2
Dhanasekaran, S.M.3
Helgeson, B.E.4
Cao, X.5
Morris, D.S.6
-
10
-
-
44449139593
-
The role of spink1 in ets rearrangement-negative prostate cancers
-
Tomlins SA, Rhodes DR, Yu J, Varambally S, Mehra R, Perner S, et al. The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell 2008;13:519-28.
-
(2008)
Cancer Cell
, vol.13
, pp. 519-28
-
-
Tomlins, S.A.1
Rhodes, D.R.2
Yu, J.3
Varambally, S.4
Mehra, R.5
Perner, S.6
-
11
-
-
77954526989
-
Rearrangements of therafkinase pathway in prostate cancer, gastric cancer and melanoma
-
Palanisamy N, Ateeq B, Kalyana-Sundaram S, Pflueger D, Ramnarayanan K, Shankar S, et al. Rearrangements of theRAFkinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med 2010;16: 793-8.
-
(2010)
Nat Med
, vol.16
, pp. 793-8
-
-
Palanisamy, N.1
Ateeq, B.2
Kalyana-Sundaram, S.3
Pflueger, D.4
Ramnarayanan, K.5
Shankar, S.6
-
13
-
-
44949204525
-
Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer
-
Setlur SR, Mertz KD, Hoshida Y, Demichelis F, Lupien M, Perner S, et al. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. J Natl Cancer Inst 2008;100: 815-25.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 815-25
-
-
Setlur, S.R.1
Mertz, K.D.2
Hoshida, Y.3
Demichelis, F.4
Lupien, M.5
Perner, S.6
-
14
-
-
79951497419
-
The genomic complexity of primary human prostate cancer
-
Berger MF, Lawrence MS, Demichelis F, Drier Y, Cibulskis K, Sivachenko AY, et al. The genomic complexity of primary human prostate cancer. Nature 2011;470:214-20.
-
(2011)
Nature
, vol.470
, pp. 214-20
-
-
Berger, M.F.1
Lawrence, M.S.2
Demichelis, F.3
Drier, Y.4
Cibulskis, K.5
Sivachenko, A.Y.6
-
15
-
-
84863723010
-
The mutational landscape of lethal castration-resistant prostate cancer
-
Grasso CS,WuYM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 2012;487:239-43.
-
(2012)
Nature
, vol.487
, pp. 239-43
-
-
Grasso, C.S.1
Wu, Y.M.2
Robinson, D.R.3
Cao, X.4
Dhanasekaran, S.M.5
Khan, A.P.6
-
16
-
-
77955660663
-
Diverse somatic mutation patterns and pathway alterations in human cancers
-
Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, Stern HM, et al. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 2010;466:869-73.
-
(2010)
Nature
, vol.466
, pp. 869-73
-
-
Kan, Z.1
Jaiswal, B.S.2
Stinson, J.3
Janakiraman, V.4
Bhatt, D.5
Stern, H.M.6
-
17
-
-
80054751998
-
Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers
-
Kumar A, White TA, MacKenzie AP, Clegg N, Lee C, Dumpit RF, et al. Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers. Proc Natl Acad Sci U S A 2011; 108:17087-92.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 17087-92
-
-
Kumar, A.1
White, T.A.2
MacKenzie, A.P.3
Clegg, N.4
Lee, C.5
Dumpit, R.F.6
-
18
-
-
84861581164
-
Exome sequencing identifies recurrent spop, foxa1 and med12 mutations in prostate cancer
-
Barbieri CE, Baca SC, Lawrence MS, Demichelis F, Blattner M, Theurillat JP, et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet 2012; 44:685-9.
-
(2012)
Nat Genet
, vol.44
, pp. 685-9
-
-
Barbieri, C.E.1
Baca, S.C.2
Lawrence, M.S.3
Demichelis, F.4
Blattner, M.5
Theurillat, J.P.6
-
19
-
-
84862907206
-
Genome interrupted: Sequencing of prostate cancer reveals the importance of chromosomal rearrangements
-
Kumar A, Shendure J, Nelson PS. Genome interrupted: sequencing of prostate cancer reveals the importance of chromosomal rearrangements. Genome Med 2011;3:23.
-
(2011)
Genome Med
, vol.3
, pp. 23
-
-
Kumar, A.1
Shendure, J.2
Nelson, P.S.3
-
20
-
-
0028817021
-
Association of p53 mutations with metastatic prostate cancer
-
Eastham JA, Stapleton AM, Gousse AE, Timme TL, Yang G, Slawin KM, et al. Association of p53 mutations with metastatic prostate cancer. Clin Cancer Res 1995;1:1111-8.
-
(1995)
Clin Cancer Res
, vol.1
, pp. 1111-8
-
-
Eastham, J.A.1
Stapleton, A.M.2
Gousse, A.E.3
Timme, T.L.4
Yang, G.5
Slawin, K.M.6
-
21
-
-
15444349266
-
Frequent inactivation of pten/mmac1 in primary prostate cancer
-
Cairns P, Okami K, Halachmi S, Halachmi N, Esteller M, Herman JG, et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Res 1997;57:4997-5000.
-
(1997)
Cancer Res
, vol.57
, pp. 4997-5000
-
-
Cairns, P.1
Okami, K.2
Halachmi, S.3
Halachmi, N.4
Esteller, M.5
Herman, J.G.6
-
22
-
-
84876831537
-
Prostate cancer-Associated mutations in speckle-type poz protein (spop) regulate steroid receptor coactivator 3 protein turnover
-
Geng C, He B, Xu L, Barbieri CE, Eedunuri VK, Chew SA, et al. Prostate cancer-Associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. Proc Natl Acad Sci U S A 2013;110:6997-7002.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, pp. 6997-7002
-
-
Geng, C.1
He, B.2
Xu, L.3
Barbieri, C.E.4
Eedunuri, V.K.5
Chew, S.A.6
-
23
-
-
67349257845
-
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
-
Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G, et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009;15:559-65.
-
(2009)
Nat Med
, vol.15
, pp. 559-65
-
-
Liu, W.1
Laitinen, S.2
Khan, S.3
Vihinen, M.4
Kowalski, J.5
Yu, G.6
-
24
-
-
70350223620
-
Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer
-
Holcomb IN, Young JM, Coleman IM, Salari K, Grove DI, Hsu L, et al. Comparative analyses of chromosome alterations in soft-tissue metastases within and across patients with castration-resistant prostate cancer. Cancer Res 2009;69:7793-802.
-
(2009)
Cancer Res
, vol.69
, pp. 7793-802
-
-
Holcomb, I.N.1
Young, J.M.2
Coleman, I.M.3
Salari, K.4
Grove, D.I.5
Hsu, L.6
-
25
-
-
78651521293
-
Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors
-
Robbins CM, Tembe WA, Baker A, Sinari S, Moses TY, Beckstrom-Sternberg S, et al. Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors. Genome Res 2011;21:47-55.
-
(2011)
Genome Res
, vol.21
, pp. 47-55
-
-
Robbins, C.M.1
Tembe, W.A.2
Baker, A.3
Sinari, S.4
Moses, T.Y.5
Beckstrom-Sternberg, S.6
-
26
-
-
34548496025
-
Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone
-
Askew EB, Gampe RT Jr., Stanley TB, Faggart JL, Wilson EM. Modulation of androgen receptor activation function 2 by testosterone and dihydrotestosterone. J Biol Chem 2007;282:25801-16.
-
(2007)
J Biol Chem
, vol.282
, pp. 25801-16
-
-
Askew, E.B.1
Gampe Jr., R.T.2
Stanley, T.B.3
Faggart, J.L.4
Wilson, E.M.5
-
27
-
-
53349141341
-
2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-Activated protein kinase pathways
-
Shah S, Hess-Wilson JK, Webb S, Daly H, Godoy-Tundidor S, Kim J, et al. 2,2-bis(4-chlorophenyl)-1,1-dichloroethylene stimulates androgen independence in prostate cancer cells through combinatorial activation of mutant androgen receptor and mitogen-Activated protein kinase pathways. Mol Cancer Res 2008;6:1507-20.
-
(2008)
Mol Cancer Res
, vol.6
, pp. 1507-20
-
-
Shah, S.1
Hess-Wilson, J.K.2
Webb, S.3
Daly, H.4
Godoy-Tundidor, S.5
Kim, J.6
-
28
-
-
84879067087
-
Overcoming mutation-based resistance to antiandrogens with rational drug design
-
Balbas MD, Evans MJ, Hosfield DJ, Wongvipat J, Arora VK, Watson PA, et al. Overcoming mutation-based resistance to antiandrogens with rational drug design. eLife 2013;2:e00499.
-
(2013)
ELife
, vol.2
-
-
Balbas, M.D.1
Evans, M.J.2
Hosfield, D.J.3
Wongvipat, J.4
Arora, V.K.5
Watson, P.A.6
-
29
-
-
33751304953
-
Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer
-
Agoulnik IU, Vaid A, Nakka M, Alvarado M, Bingman WE III, Erdem H, et al. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer. Cancer Res 2006;66:10594-602.
-
(2006)
Cancer Res
, vol.66
, pp. 10594-602
-
-
Agoulnik, I.U.1
Vaid, A.2
Nakka, M.3
Alvarado, M.4
Bingman III, W.E.5
Erdem, H.6
-
30
-
-
77955069195
-
Androgen-induced top2b-mediated double-strand breaks and prostate cancer gene rearrangements
-
Haffner MC, Aryee MJ, Toubaji A, Esopi DM, Albadine R, Gurel B, et al. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet 2010;42: 668-75.
-
(2010)
Nat Genet
, vol.42
, pp. 668-75
-
-
Haffner, M.C.1
Aryee, M.J.2
Toubaji, A.3
Esopi, D.M.4
Albadine, R.5
Gurel, B.6
-
31
-
-
71249101060
-
Nuclear receptorinduced chromosomal proximity and dna breaks underlie specific translocations in cancer
-
Lin C, Yang L, Tanasa B, Hutt K, Ju BG, Ohgi K, et al. Nuclear receptorinduced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 2009;139:1069-83.
-
(2009)
Cell
, vol.139
, pp. 1069-83
-
-
Lin, C.1
Yang, L.2
Tanasa, B.3
Hutt, K.4
Ju, B.G.5
Ohgi, K.6
-
32
-
-
84861860413
-
Oncogene-mediated alterations in chromatin conformation
-
Rickman DS, Soong TD,Moss B, Mosquera JM, Dlabal J, Terry S, et al. Oncogene-mediated alterations in chromatin conformation. Proc Natl Acad Sci U S A 2012;109:9083-8.
-
(2012)
Proc Natl Acad Sci U S A
, vol.109
, pp. 9083-8
-
-
Rickman, D.S.1
Soong, T.D.2
Moss, B.3
Mosquera, J.M.4
Dlabal, J.5
Terry, S.6
-
33
-
-
70849135782
-
Induced chromosomal proximity and gene fusions in prostate cancer
-
Mani RS, Tomlins SA, Callahan K, Ghosh A, Nyati MK, Varambally S, et al. Induced chromosomal proximity and gene fusions in prostate cancer. Science 2009;326:1230.
-
(2009)
Science
, vol.326
, pp. 1230
-
-
Mani, R.S.1
Tomlins, S.A.2
Callahan, K.3
Ghosh, A.4
Nyati, M.K.5
Varambally, S.6
-
34
-
-
84866390624
-
Recurrent deletion of chd1 in prostate cancer with relevance to cell invasiveness
-
Huang S, Gulzar ZG, Salari K, Lapointe J, Brooks JD, Pollack Jr. Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness. Oncogene 2012;31:4164-70.
-
(2012)
Oncogene
, vol.31
, pp. 4164-70
-
-
Huang, S.1
Gulzar, Z.G.2
Salari, K.3
Lapointe, J.4
Brooks, J.D.5
Pollack, J.R.6
-
35
-
-
84858207248
-
Chd5, a tumor suppressor that is epigenetically silenced in lung cancer
-
Zhao R, Yan Q, Lv J, Huang H, Zheng W, Zhang B, et al. CHD5, a tumor suppressor that is epigenetically silenced in lung cancer. Lung Cancer 2012;76:324-31.
-
(2012)
Lung Cancer
, vol.76
, pp. 324-31
-
-
Zhao, R.1
Yan, Q.2
Lv, J.3
Huang, H.4
Zheng, W.5
Zhang, B.6
-
36
-
-
84860611228
-
Chromodomain helicase dna binding protein 5 plays a tumor suppressor role in human breast cancer
-
WuX, Zhu Z, Li W, Fu X, Su D, Fu L, et al. Chromodomain helicase DNA binding protein 5 plays a tumor suppressor role in human breast cancer. Breast Cancer Res 2012;14:R73.
-
(2012)
Breast Cancer Res
, vol.14
-
-
WuX Zhu, Z.1
Li, W.2
Fu, X.3
Su, D.4
Fu, L.5
-
37
-
-
33846703338
-
Chd5 is a tumor suppressor at human 1p36
-
Bagchi A, Papazoglu C,Wu Y, Capurso D, Brodt M, Francis D, et al. CHD5 is a tumor suppressor at human 1p36. Cell 2007;128: 459-75.
-
(2007)
Cell
, vol.128
, pp. 459-75
-
-
Bagchi, A.1
Papazoglu, C.2
Wu, Y.3
Capurso, D.4
Brodt, M.5
Francis, D.6
-
38
-
-
84864419974
-
Dissecting the genomic complexity underlying medulloblastoma
-
Jones DT, Jager N, Kool M, Zichner T, Hutter B, Sultan M, et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 2012;488:100-5.
-
(2012)
Nature
, vol.488
, pp. 100-5
-
-
Jones, D.T.1
Jager, N.2
Kool, M.3
Zichner, T.4
Hutter, B.5
Sultan, M.6
-
39
-
-
80052029516
-
Frequent mutation of histone-modifying genes in non-hodgkin lymphoma
-
Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 2011;476:298-303.
-
(2011)
Nature
, vol.476
, pp. 298-303
-
-
Morin, R.D.1
Mendez-Lago, M.2
Mungall, A.J.3
Goya, R.4
Mungall, K.L.5
Corbett, R.D.6
-
40
-
-
79960026150
-
Deciphering the role of forkhead transcription factors in cancer therapy
-
Yang JY, Hung MC. Deciphering the role of forkhead transcription factors in cancer therapy. Curr Drug Targets 2011;12:1284-90.
-
(2011)
Curr Drug Targets
, vol.12
, pp. 1284-90
-
-
Yang, J.Y.1
Hung, M.C.2
-
41
-
-
80053610846
-
Dual role of foxa1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
-
Sahu B, Laakso M, Ovaska K, Mirtti T, Lundin J, Rannikko A, et al. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer. EMBO J 2011;30:3962-76.
-
(2011)
EMBO J
, vol.30
, pp. 3962-76
-
-
Sahu, B.1
Laakso, M.2
Ovaska, K.3
Mirtti, T.4
Lundin, J.5
Rannikko, A.6
-
42
-
-
24344447360
-
Forkhead box a1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation
-
Gao N, Ishii K, Mirosevich J, Kuwajima S, Oppenheimer SR, Roberts RL, et al. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation. Development 2005;132: 3431-43.
-
(2005)
Development
, vol.132
, pp. 3431-43
-
-
Gao, N.1
Ishii, K.2
Mirosevich, J.3
Kuwajima, S.4
Oppenheimer, S.R.5
Roberts, R.L.6
-
43
-
-
84864532021
-
Foxa1 promotes tumor progression in prostate cancer via the insulinlike growth factor binding protein 3 pathway
-
Imamura Y, Sakamoto S, Endo T, Utsumi T, Fuse M, Suyama T, et al. FOXA1 promotes tumor progression in prostate cancer via the insulinlike growth factor binding protein 3 pathway. PLoS One 2012;7: e42456.
-
(2012)
PLoS One
, vol.7
-
-
Imamura, Y.1
Sakamoto, S.2
Endo, T.3
Utsumi, T.4
Fuse, M.5
Suyama, T.6
-
44
-
-
84870376109
-
Cancer genetics and genomics of human fox family genes
-
Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M. Cancer genetics and genomics of human FOX family genes. Cancer Lett 2013; 328:198-206.
-
(2013)
Cancer Lett
, vol.328
, pp. 198-206
-
-
Katoh, M.1
Igarashi, M.2
Fukuda, H.3
Nakagama, H.4
Katoh, M.5
-
45
-
-
33746930170
-
Foxo1a is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer
-
Dong XY, Chen C, Sun X, Guo P, Vessella RL, Wang RX, et al. FOXO1A is a candidate for the 13q14 tumor suppressor gene inhibiting androgen receptor signaling in prostate cancer. Cancer Res 2006;66:6998-7006.
-
(2006)
Cancer Res
, vol.66
, pp. 6998-7006
-
-
Dong, X.Y.1
Chen, C.2
Sun, X.3
Guo, P.4
Vessella, R.L.5
Wang, R.X.6
-
46
-
-
57749083377
-
A transcription-independent function of foxo1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells
-
Liu P, Li S, Gan L, Kao TP, Huang H. A transcription-independent function of FOXO1 in inhibition of androgen-independent activation of the androgen receptor in prostate cancer cells. Cancer Res 2008;68: 10290-9.
-
(2008)
Cancer Res
, vol.68
, pp. 10290-9
-
-
Liu, P.1
Li, S.2
Gan, L.3
Kao, T.P.4
Huang, H.5
-
47
-
-
79960715027
-
The pro-longevity gene foxo3 is a direct target of the p53 tumor suppressor
-
Renault VM, Thekkat PU, Hoang KL, White JL, Brady CA, Kenzelmann Broz D, et al. The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor. Oncogene 2011;30:3207-21.
-
(2011)
Oncogene
, vol.30
, pp. 3207-21
-
-
Renault, V.M.1
Thekkat, P.U.2
Hoang, K.L.3
White, J.L.4
Brady, C.A.5
Kenzelmann Broz, D.6
-
48
-
-
45249094084
-
Significance of nuclear accumulation of foxo3a in esophageal squamous cell carcinoma
-
Chen MF, Fang FM, Lu CH, Lu MS, Chen WC, Lee KD, et al. Significance of nuclear accumulation of Foxo3a in esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2008;71:1220-9.
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.71
, pp. 1220-9
-
-
Chen, M.F.1
Fang, F.M.2
Lu, C.H.3
Lu, M.S.4
Chen, W.C.5
Lee, K.D.6
-
49
-
-
27844506524
-
Akt-regulated pathways in prostate cancer
-
Majumder PK, Sellers WR. Akt-regulated pathways in prostate cancer. Oncogene 2005;24:7465-74.
-
(2005)
Oncogene
, vol.24
, pp. 7465-74
-
-
Majumder, P.K.1
Sellers, W.R.2
-
50
-
-
38449120211
-
Role of pten gene in progression of prostate cancer
-
Pourmand G, Ziaee AA, Abedi AR, Mehrsai A, Alavi HA, Ahmadi A, et al. Role of PTEN gene in progression of prostate cancer. Urol J 2007;4:95-100.
-
(2007)
Urol J
, vol.4
, pp. 95-100
-
-
Pourmand, G.1
Ziaee, A.A.2
Abedi, A.R.3
Mehrsai, A.4
Alavi, H.A.5
Ahmadi, A.6
-
51
-
-
78751535990
-
Decreased expression and androgen regulation of the tumor suppressor gene inpp4b in prostate cancer
-
Hodgson MC, Shao LJ, Frolov A, Li R, Peterson LE, Ayala G, et al. Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. Cancer Res 2011;71: 572-82.
-
(2011)
Cancer Res
, vol.71
, pp. 572-82
-
-
Hodgson, M.C.1
Shao, L.J.2
Frolov, A.3
Li, R.4
Peterson, L.E.5
Ayala, G.6
-
52
-
-
80051579092
-
Identification of phlpp1 as a tumor suppressor reveals the role of feedback activation in pten-mutant prostate cancer progression
-
Chen M, Pratt CP, Zeeman ME, Schultz N, Taylor BS, O'Neill A, et al. Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression. Cancer Cell 2011;20:173-86.
-
(2011)
Cancer Cell
, vol.20
, pp. 173-86
-
-
Chen, M.1
Pratt, C.P.2
Zeeman, M.E.3
Schultz, N.4
Taylor, B.S.5
O'Neill, A.6
-
53
-
-
0242525635
-
Gene amplifications associated with the development of hormone-resistant prostate cancer
-
Edwards J, Krishna NS, Witton CJ, Bartlett JM. Gene amplifications associated with the development of hormone-resistant prostate cancer. Clin Cancer Res 2003;9:5271-81.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 5271-81
-
-
Edwards, J.1
Krishna, N.S.2
Witton, C.J.3
Bartlett, J.M.4
-
54
-
-
67650074847
-
Genetic alterations in the pi3k pathway in prostate cancer
-
Sun X, Huang J, Homma T, Kita D, Klocker H, Schafer G, et al. Genetic alterations in the PI3K pathway in prostate cancer. Anticancer Res 2009;29:1739-43.
-
(2009)
Anticancer Res
, vol.29
, pp. 1739-43
-
-
Sun, X.1
Huang, J.2
Homma, T.3
Kita, D.4
Klocker, H.5
Schafer, G.6
-
55
-
-
84871920313
-
Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins
-
Lindberg J, Klevebring D, Liu W, Neiman M, Xu J, Wiklund P, et al. Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins. Eur Urol 2013;63:347-53.
-
(2013)
Eur Urol
, vol.63
, pp. 347-53
-
-
Lindberg, J.1
Klevebring, D.2
Liu, W.3
Neiman, M.4
Xu, J.5
Wiklund, P.6
-
56
-
-
79953766940
-
Tumour evolution inferred by single-cell sequencing
-
Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011;472: 90-4.
-
(2011)
Nature
, vol.472
, pp. 90-4
-
-
Navin, N.1
Kendall, J.2
Troge, J.3
Andrews, P.4
Rodgers, L.5
McIndoo, J.6
-
57
-
-
84863229772
-
Single-cell exome sequencing and monoclonal evolution of a jak2-negative myeloproliferative neoplasm
-
Hou Y, Song L, Zhu P, Zhang B, Tao Y, Xu X, et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 2012;148:873-85.
-
(2012)
Cell
, vol.148
, pp. 873-85
-
-
Hou, Y.1
Song, L.2
Zhu, P.3
Zhang, B.4
Tao, Y.5
Xu, X.6
-
58
-
-
84863230091
-
Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor
-
Xu X, Hou Y, Yin X, Bao L, Tang A, Song L, et al. Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 2012;148:886-95.
-
(2012)
Cell
, vol.148
, pp. 886-95
-
-
Xu, X.1
Hou, Y.2
Yin, X.3
Bao, L.4
Tang, A.5
Song, L.6
-
59
-
-
84863393080
-
Intratumor heterogeneity and branched evolution revealed by multiregion sequencing
-
Gerlinger M, Rowan AJ, Horswell S, Larkin J, Endesfelder D, Gronroos E, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012;366:883-92.
-
(2012)
N Engl J Med
, vol.366
, pp. 883-92
-
-
Gerlinger, M.1
Rowan, A.J.2
Horswell, S.3
Larkin, J.4
Endesfelder, D.5
Gronroos, E.6
-
60
-
-
73649123907
-
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in pdgfra, idh1, egfr, and nf1
-
Verhaak RG, Hoadley KA, Purdom E,WangV, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010;17:98-110.
-
(2010)
Cancer Cell
, vol.17
, pp. 98-110
-
-
Verhaak, R.G.1
Hoadley, K.A.2
Purdom, E.3
Wang, V.4
Qi, Y.5
Wilkerson, M.D.6
-
61
-
-
79959911384
-
Deep sequencing reveals distinct patterns of dna methylation in prostate cancer
-
Kim JH, DhanasekaranSM, Prensner JR, Cao X, Robinson D, Kalyana-Sundaram S, et al. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome Res 2011;21:1028-41.
-
(2011)
Genome Res
, vol.21
, pp. 1028-41
-
-
Kim, J.H.1
Dhanasekaran, S.M.2
Prensner, J.R.3
Cao, X.4
Robinson, D.5
Kalyana-Sundaram, S.6
-
62
-
-
34548567066
-
Integrative analysis of genomic aberrations associated with prostate cancer progression
-
Kim JH, Dhanasekaran SM, Mehra R, Tomlins SA, Gu W, Yu J, et al. Integrative analysis of genomic aberrations associated with prostate cancer progression. Cancer Res 2007;67:8229-39.
-
(2007)
Cancer Res
, vol.67
, pp. 8229-39
-
-
Kim, J.H.1
Dhanasekaran, S.M.2
Mehra, R.3
Tomlins, S.A.4
Gu, W.5
Yu, J.6
-
63
-
-
79955497591
-
Genomic differences between estrogen receptor (er)-positive and ernegative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis
-
Fang M, Toher J, Morgan M, Davison J, Tannenbaum S, Claffey K. Genomic differences between estrogen receptor (ER)-positive and ERnegative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis. Cancer 2011;117:2024-34.
-
(2011)
Cancer
, vol.117
, pp. 2024-34
-
-
Fang, M.1
Toher, J.2
Morgan, M.3
Davison, J.4
Tannenbaum, S.5
Claffey, K.6
-
64
-
-
62149133119
-
Distinct genomic aberrations associated with erg rearranged prostate cancer
-
Demichelis F, Setlur SR, Beroukhim R, Perner S, Korbel JO, Lafargue CJ, et al. Distinct genomic aberrations associated with ERG rearranged prostate cancer. Genes Chromosomes Cancer 2009;48: 366-80.
-
(2009)
Genes Chromosomes Cancer
, vol.48
, pp. 366-80
-
-
Demichelis, F.1
Setlur, S.R.2
Beroukhim, R.3
Perner, S.4
Korbel, J.O.5
Lafargue, C.J.6
-
65
-
-
84856961660
-
Circulating tumor cells in prostate cancer: A potential surrogate marker of survival
-
Doyen J, Alix-Panabieres C, Hofman P, Parks SK, Chamorey E,Naman H, et al. Circulating tumor cells in prostate cancer: a potential surrogate marker of survival. Crit Rev Oncol Hematol 2012;81:241-56.
-
(2012)
Crit Rev Oncol Hematol
, vol.81
, pp. 241-56
-
-
Doyen, J.1
Alix-Panabieres, C.2
Hofman, P.3
Parks, S.K.4
Chamorey, E.5
Naman, H.6
-
66
-
-
64549101978
-
Detection of circulating tumor cells in prostate cancer patients: Methodological pitfalls and clinical relevance
-
Panteleakou Z, Lembessis P, Sourla A, Pissimissis N, Polyzos A, Deliveliotis C, et al. Detection of circulating tumor cells in prostate cancer patients: methodological pitfalls and clinical relevance. Mol Med 2009;15:101-14.
-
(2009)
Mol Med
, vol.15
, pp. 101-14
-
-
Panteleakou, Z.1
Lembessis, P.2
Sourla, A.3
Pissimissis, N.4
Polyzos, A.5
Deliveliotis, C.6
-
67
-
-
84875520648
-
Analysis of circulating tumor dna to monitor metastatic breast cancer
-
Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 2013;368:1199-209.
-
(2013)
N Engl J Med
, vol.368
, pp. 1199-209
-
-
Dawson, S.J.1
Tsui, D.W.2
Murtaza, M.3
Biggs, H.4
Rueda, O.M.5
Chin, S.F.6
-
68
-
-
84856530618
-
Common structural and epigenetic changes in the genome of castration-resistant prostate cancer
-
Friedlander TW, Roy R, Tomlins SA, Ngo VT, Kobayashi Y, Azameera A, et al. Common structural and epigenetic changes in the genome of castration-resistant prostate cancer. Cancer Res 2012;72:616-25.
-
(2012)
Cancer Res
, vol.72
, pp. 616-25
-
-
Friedlander, T.W.1
Roy, R.2
Tomlins, S.A.3
Ngo, V.T.4
Kobayashi, Y.5
Azameera, A.6
-
69
-
-
84862782971
-
Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer
-
Magbanua MJ, Sosa EV, Scott JH, Simko J, Collins C, Pinkel D, et al. Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer. BMC Cancer 2012;12:78.
-
(2012)
BMC Cancer
, vol.12
, pp. 78
-
-
Magbanua, M.J.1
Sosa, E.V.2
Scott, J.H.3
Simko, J.4
Collins, C.5
Pinkel, D.6
-
70
-
-
34248139271
-
Dnacopy number alterations in prostate cancers: A combined analysis of published cgh studies
-
Sun J, Liu W, Adams TS, Sun J, Li X, Turner AR, et al.DNAcopy number alterations in prostate cancers: a combined analysis of published CGH studies. Prostate 2007;67:692-700.
-
(2007)
Prostate
, vol.67
, pp. 692-700
-
-
Sun, J.1
Liu, W.2
Adams, T.S.3
Sun, J.4
Li, X.5
Turner, A.R.6
-
71
-
-
80455160223
-
Copy number alterations in prostate tumors and disease aggressiveness
-
Cheng I, Levin AM, Tai YC, Plummer S, Chen GK, Neslund-Dudas C, et al. Copy number alterations in prostate tumors and disease aggressiveness. Genes Chromosomes Cancer 2012;51:66-76.
-
(2012)
Genes Chromosomes Cancer
, vol.51
, pp. 66-76
-
-
Cheng, I.1
Levin, A.M.2
Tai, Y.C.3
Plummer, S.4
Chen, G.K.5
Neslund-Dudas, C.6
-
72
-
-
34548793008
-
Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis
-
Lapointe J, Li C, Giacomini CP, Salari K, Huang S, Wang P, et al. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. Cancer Res 2007;67:8504-10.
-
(2007)
Cancer Res
, vol.67
, pp. 8504-10
-
-
Lapointe, J.1
Li, C.2
Giacomini, C.P.3
Salari, K.4
Huang, S.5
Wang, P.6
-
73
-
-
67449164284
-
Highresolution array cgh identifies novel regions of genomic alteration in intermediate-risk prostate cancer
-
Ishkanian AS, Mallof CA, Ho J, Meng A, Albert M, Syed A, et al. Highresolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer. Prostate 2009;69:1091-100.
-
(2009)
Prostate
, vol.69
, pp. 1091-100
-
-
Ishkanian, A.S.1
Mallof, C.A.2
Ho, J.3
Meng, A.4
Albert, M.5
Syed, A.6
-
74
-
-
84862815211
-
Highresolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer
-
Boyd LK, Mao X, Xue L, Lin D, Chaplin T, Kudahetti SC, et al. Highresolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer. Genes Chromosomes Cancer 2012;51:579-89.
-
(2012)
Genes Chromosomes Cancer
, vol.51
, pp. 579-89
-
-
Boyd, L.K.1
Mao, X.2
Xue, L.3
Lin, D.4
Chaplin, T.5
Kudahetti, S.C.6
|